<DOC>
	<DOCNO>NCT00552877</DOCNO>
	<brief_summary>In randomize study Xience V coroary artery stent may non inferior Cypher Select+ coronary stent treatment unselected patient coronary artery disease .</brief_summary>
	<brief_title>The SOURT OUT IV TRIAL</brief_title>
	<detailed_description>2 Purpose In randomize study compare Cypher Select+ Xience V coronary stent treatment unselected patient coronary artery disease . 2.1 Primary objective In randomized study compare Xience V Cypher Select+ coronary stent assess SAFETY ( cardiac death , myocardial infarction and/or stent thrombosis ) EFFICACY ( target vessel revascularization ) 9 month . 2.2 Secondary objective To compare device success rate , procedure success rate complication rate hospitalization , 1 month 9 month incidence late stent thrombosis 12 , 24 36 month .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>All patient treat one drug elute stent coronary artery one 5 heart centre Denmark ( Gentofte , Rigshospitalet , Odense , Skejby , Aalborg ) include study . The patient participate The patient participates randomise stent study Expected survival &lt; 1 year Allergy Aspirin , Clopidogrel Ticlopidine Allergy Sirolimus ABT578</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>PCI</keyword>
	<keyword>Drug-eluting stent</keyword>
</DOC>